P-75: Role of Anti-Mullerian Hormone in Prediction of Assisted Reproductive Technology Outcomes

Background: Anti-Mullerian hormone (AMH) has been suggested as a marker of ovarian reserve and predictor of ovarian response to controlled ovarian hyper stimulation. The aim of this study is to determine the role of AMH in prediction of success ART cycles in patients with normal FSH serum levels. Materials and Methods: This prospective cohort study included 80 infertile women under 4o years, who candidates for assisted reproductive technique. Serum AMH levels on cycle day 3 were measured and all the patients underwent controlled ovarian hyper stimulation and ART. The relationship between serum AMH and ART outcomes, including oocytes number, matured oocytes, fertilization rate, implantation rate, high quality embryo, free zed embryo and biochemical and clinical pregnancy rates were evaluated. Cut-off for level of AMH in this level pregnancy is high, determined. Results: Serum basal AMH levels showed positive correlation with number of oocytes retrieved, mature oocytes, number of embryos transferred and biochemical and clinical pregnancy. Cut-off for serum AMH with and without clinical pregnancy was 3.9. Conclusion: This study showed that in pregnant women undergoing ART, AMH serum levels were higher than non pregnant women.